Finland· FI-REL-REL1003
Oftan Flurekain
A fluorescein, kombinationen product containing fluorescein sodium + oxybuprocaine hydrochloride, registered in Finland by Santen Oy. The same ATC class is registered in 7 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Fluorescein, kombinationen is registered in 7 of 19 countries.
Countries holding a registration under ATC S01JA51 (fluorescein, kombinationen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Fluorescein, kombinationen · ATC S01JA51
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Fluorescein sodium + Oxybuprocaine hydrochloride
- Manufacturer
- Santen Oy
- Country
- Finland (FI)
- ATC code
- S01JA51
- ATC class
- Fluorescein, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fluorescein, kombinationen in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesALTAFLUORAltaire Pharmaceuticals Inc.
- GermanyThilorbinOmnivision Gmbh
- SpainCOLIROFTA FLUOTEST 2,5 MG/ML + 4 MG/ML COLIRIO EN SOLUCIÓNAlcon Healthcare S.A.
- SwitzerlandFluoresceine Oxybuprocaine SDU Faure, AugentropfenOmniVision AG
- NorwayCombiflureSanten Oy
- SwedenOptax 1,25 mg/ml + 3 mg/ml Ögondroppar, lösningSanten Oy
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Belgium · Combiflure
- Germany · Thilorbin
- Denmark · Combiflure
- Italy · Flurekain
- Luxembourg · Combiflure, Thilorbin
- Norway · Combiflure
- Portugal · Fluotest Multidose
- Sweden · Optax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9cfd7575-f1c1-4470-a49c-f26facd7edb7 GET /v1/drugs/9cfd7575-f1c1-4470-a49c-f26facd7edb7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmätipat, liuos",
"route": null,
"ddd_unit": null,
"strength": null,
"atc_label": "fluoreseiini, yhdistelmävalmisteet",
"ma_number": "6957",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL1003",
"authorised_at": "1974-10-30"
}See everything about fluorescein, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.